How Microbiome Data is Transforming Veterinary Medicine | Dr. Bushra Schuitemaker, Ph.D. - Head of Microbiology, Pooch & Mutt - Head of Science and Research, BIOME9

Episode notes

Send us Fan Mail There’s a revolution happening in pet health right now - where a simple stool sample can reveal disease risk, immune health, and even how long your dog might live. Dr. Bushra Schuitemaker, Ph.D. is a microbiologist, zoologist, and science leader working at the cutting edge of microbiome research, animal health, and nutrition. Dr. Schuitemaker serves as Head of Science and Research at BIOME9 ( ), a leading platform for canine gut microbiome analysis, and Head of Microbiology at Pooch & Mutt ( ), where she helps translate microbiome science into real-world products and interventions for pet health. Dr. Schuitemaker’s work sits at the intersection of microbial ecology, bioinformatics, and machine learning, where she develops tools to decode the gut microbiome and turn complex data into actionable insights for veterinarians, pet owners, and the pet food industry. Her expertise spans metagenomics, metabolomics, and multi-omics integration, with a focus on identifying biomarkers that can drive precision health approaches in animals. Dr. Schuitemaker completed her Ph.D.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• 114: Beyond Water: Building the Next Generation of Hydration with LemondayEat. Drink. Social · on gut health52 / 100
• How to Make People Understand YouProblem Solvers · on gut health49 / 100
• Success Leaves Clues: Ep242 - "Letting Go is the Way Forward" - with guest Subhi Alsayed, Founder/CEO of Kulture RebellionSuccess Leaves Clues with Robin Bailey and Al McDonald · on gut health

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton
• Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.
• The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart Institute
• The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen